Vehicle of the test product

DRUG4 trials

Sponsors

Sun Pharmaceutical Industries, Inc.

Conditions

Acne VulgarisLice; Head LiceRosacea

Early Phase 1

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris

CompletedNCT03427554

Sun Pharmaceutical Industries, Inc.Acne Vulgaris

Start: 2017-08-21End: 2018-01-26Updated: 2018-05-18

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

CompletedNCT03433378

Sun Pharmaceutical Industries, Inc.Acne Vulgaris

Start: 2017-08-04End: 2018-01-26Updated: 2018-05-18

Phase 1

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

CompletedNCT03257943

Sun Pharmaceutical Industries, Inc.Lice; Head Lice

Start: 2017-03-20End: 2017-08-18Updated: 2018-05-18

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

CompletedNCT03689010

Sun Pharmaceutical Industries, Inc.Rosacea

Start: 2017-12-12End: 2018-09-28Updated: 2019-03-19